Clinical trials with REACT® have shown promising early efficacy and safety results. Individuals with Stage 3 and 4 type 2 diabetic CKD are target populations for restoration and stabilization of renal ...
For Web developers, making the jump to building full-fledged smartphone apps can be daunting. Facebook could ease the transition with a newly open-sourced framework its engineers developed to build ...
WINSTON-SALEM, N.C., June 23, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (ProKidney), a leading clinical-stage cellular therapeutics company focused on the treatment of chronic kidney disease (CKD) and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback